C vs USBC
Citigroup Inc. (C) versus US BioTec Inc (USBC) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
US BioTec Inc (USBC) is a agricultural inputs company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported USBC revenue for 2023-09-30 was $0. Net income was -$15.3M. Revenue was down 100.0% from 2022-09-30 to 2023-09-30. USBC currently screens at market cap $0.
C currently screens at market cap $214.73B and trailing P/E 15.5. USBC currently screens at market cap $0.
Not investment advice. Open the C and USBC stock pages for the full models.
Not investment advice.